ANIXAnixa Biosciences, Inc.

ANIX Stock Price, Valuation & Chart | Anixa Biosciences, Inc.

Compare

$3.130-0.15 (-4.57%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ANIX intrinsic value ANIX calculated fair value vs price

Overview Financials Dividends Ratios

ANIX Historical price chart

ANIX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization106.49M

PE Ratio-10.1

EPS-0.31

Trading Volume332.25K

Today's High/Low3.38/3.12

Dividend Yield0.00

52 Week High/Low5.46/2.32

Shares Outstanding34.02M

ANIX Financial Statement

ANIX Analyst ratings

ANIX Analysis & performance metrics

ANIX Company profile

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's…

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the…

ANIX Management team

Name

Position

Amit Kumar Ph.D.CEO

Chief Executive Officer, Chairman & Co-Chair of CBAB

Michael J. Catelani CPA, MBACFO

President, Chief Operating Officer, Chief Financial Officer & Corporate Secretary

Pamela D. Garzone Ph.D.

Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

Name

Position

Amit Kumar Ph.D.CEO

Chief Executive Officer, Chairman & Co-Chair of CBAB

Michael J. Catelani CPA, MBACFO

President, Chief Operating Officer, Chief Financial Officer & Corporate Secretary

Pamela D. Garzone Ph.D.

Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

Management Team

Amit Kumar Ph.D.CEO

Chief Executive Officer, Chairman & Co-Chair of CBAB

Michael J. Catelani CPA, MBACFO

President, Chief Operating Officer, Chief Financial Officer & Corporate Secretary

Pamela D. Garzone Ph.D.

Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

Management

Amit Kumar Ph.D.CEO

Chief Executive Officer, Chairman & Co-Chair of CBAB

Michael J. Catelani CPA, MBACFO

President, Chief Operating Officer, Chief Financial Officer & Corporate Secretary

Pamela D. Garzone Ph.D.

Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

Total 3 executives

ANIX Frequently asked questions

What is Anixa Biosciences, Inc. (ANIX) Stock Price?

Current stock price of Anixa Biosciences, Inc. (ANIX) stock is $3.130. The stock price is -4.57% lower in the session. The intraday range can be seen from this page. Volume of Anixa Biosciences, Inc. (ANIX) stock is 332.25K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Anixa Biosciences, Inc. (ANIX) stock price going up or down today?

The stock price of Anixa Biosciences, Inc. (ANIX) can change with earnings, company news, and overall market sentiment. Anixa Biosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Anixa Biosciences, Inc. stock expensive at its current price?

Whether Anixa Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ANIX on this page is -10.10. EPS on this page is -0.31. Compare those figures with peers and growth expectations before deciding if the current Anixa Biosciences, Inc. price is justified.

How has the stock price of Anixa Biosciences, Inc. (ANIX) performed historically?

Historical performance for Anixa Biosciences, Inc. (ANIX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ANIX reacted to past earnings and market events.

Should I buy Anixa Biosciences, Inc. (ANIX) stock, at this price?

Buying Anixa Biosciences, Inc. (ANIX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.